在国家集中制药采购政策下,影响仿制药替代行为的机制
Fanyu Lin1, Haoye Li1, Keying Zhu1
1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, People's Republic of China.
Journal of pharmaceutical policy and practice
|September 11, 2025
概括
医生 医生 医生
科学领域:
- 卫生经济学 卫生经济学
- 行为科学 行为科学
- 制药政策 制药政策
背景情况:
- 中国国家集中制药采购 (NCDP) 政策影响了医生对仿制药的处方行为.
- 了解医生决策对于优化NCDP和促进仿制药替代至关重要.
研究的目的:
- 调查影响医生决定在NCDP下处方获胜的仿制药的机制.
- 为政策优化和更广泛的通用替代策略提供经验证据.
主要方法:
- 基于计划行为理论 (TPB) 开发了一个概念模型.
- 构建了一个尺度,并使用结构方程建模 (SEM) 来分析态度,规范,控制,意愿和行为之间的关系.
主要成果:
- 医生的主观态度是处方仿制药意图的主要驱动因素.
- 感知到的行为控制对意图产生了负面影响,而主观规范没有显著的影响.
- 主观意愿批判性地调解了意图和实际替代行为之间的关系.
结论:
- 提高医生的积极态度和感知到的行为控制是增加通用处方的关键.
- 培养有利的环境可以加强处方意图和NCDP实施.
- 战略应侧重于改善医生态度和愿意促进仿制药替代和降低成本.
更多相关视频
相关概念视频
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
154
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
154
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Drug Control Governance: Regulatory Bodies and Their Impact
497
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
497
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
174
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
174
Drug Products: Biologics, Biosimilars and Interchangeables
235
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
235
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
179
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179


